# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Andre Salles initiates coverage on Afya (NASDAQ:AFYA) with a Neutral rating and announces Price Target of $19.5.
Afya Limited (NASDAQ:AFYA, B3: A2FY34))) ("Afya" or the "Company"), the leading medical education group and med...
Morgan Stanley analyst Mauricio Cepeda maintains Afya (NASDAQ:AFYA) with a Equal-Weight and lowers the price target from $21...
Afya (NASDAQ:AFYA) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.45 by 22.22 p...
Afya Limited (NASDAQ:AFYA, B3: A2FY34))) ("Afya" or the "Company"), the leading medical education group and dig...